SOD2
氧化应激
超氧化物歧化酶
活性氧
内分泌学
内科学
内皮功能障碍
化学
药理学
线粒体ROS
血管紧张素II
超氧化物
生物化学
医学
血压
酶
作者
Anna Dikalova,Mingfang Ao,Liliya Tkachuk,Sergey Dikalov
出处
期刊:American Journal of Physiology-heart and Circulatory Physiology
[American Physiological Society]
日期:2024-06-21
被引量:1
标识
DOI:10.1152/ajpheart.00162.2024
摘要
Almost one-half of adults have hypertension, and blood pressure is poorly controlled in a third of patients despite use of multiple drugs, likely due to mechanisms that are not affected by current treatments. Hypertension is linked to oxidative stress; however, common antioxidants are ineffective. Hypertension is associated with inactivation of key mitochondrial antioxidant, superoxide dismutase 2 (SOD2), due to hyperacetylation but the role of specific SOD2 lysine residues has not been defined. We proposed that inactivation of key intrinsic antioxidant, SOD2, is linked to Lysine 68 acetylation, and mutation of K68 to Arginine mimics SOD2 deacetylation, inhibits vascular oxidative stress and attenuates hypertension. To test this hypothesis, we have developed a new deacetylation mimic SOD2-K68R mice. We performed
科研通智能强力驱动
Strongly Powered by AbleSci AI